神経リハビリテーション機器市場：製品、用途、エンドユーザー、地域別、2026～2032年

神経リハビリテーション機器市場の評価-2026～2032年

神経リハビリテーション機器市場では、脳卒中、パーキンソン病、脊髄損傷などの神経疾患の有病率の増加が大きな促進要因となっています。世界人口の高齢化に伴い、これらの病気の有病率が上昇し、その結果、効果的なリハビリテーションオプションに対する大きな需要が生じています。技術の向上により、患者の転帰を改善し、自立度を高める斬新な神経リハビリテーション機器が開発されています。これらの要因はすべて、神経リハビリテーション機器に対するニーズの高まりに寄与しています。市場規模は、2024年に24億6,643万米ドル、2032年には約63億7,374万米ドルに達します。

早期介入と患者中心の治療が重視されるようになり、市場拡大の原動力となっています。神経リハビリテーション機器は、より早い回復と機能的能力の向上を可能にすることで、神経障害を持つ人々の生活の質を向上させる重要な役割を果たしています。政府の支援策とヘルスケア支出の増加は、市場成長にとって有利な環境を作り出しています。こうした複合的な要因が、神経リハビリテーション機器市場の大きな成長を生み出しています。費用対効果が高く効率的な神経リハビリテーション機器に対する需要の高まりが、2026～2032年のCAGR 13.90%での市場の成長を可能にしています。

神経リハビリテーション機器市場定義/概要

神経リハビリテーション機器は、神経学的な異常を持つ人々の運動能力、感覚能力、認知能力の回復や改善を支援する特殊な機器です。これらの機器には、ロボット工学、仮想現実、ブレインコンピュータインターフェースなど、リハビリテーションプロセスを支援するさまざまな技術が用いられています。脳卒中、外傷性脳損傷、神経変性疾患などの障害を、神経細胞の可塑性と機能回復の改善を目的とした、構造化されカスタマイズ型療法を用いて治療します。

神経リハビリテーション機器は、臨床の場で利用され、患者の結果を改善する個別化されたリハビリテーションレジメンを記載しています。例えば、ロボット型外骨格は、手足の動きを誘導することによって脳卒中患者の運動機能回復を支援し、仮想現実システムは、認知・運動練習のための興味深い環境を記載しています。

これらの機器は、人工知能や機械学習の継続的な進歩により、患者独自の要求に適応する能力が向上しており、将来性が期待されています。リアルタイムのニューロフィードバックや、より先進的ブレインコンピュータインターフェースは、治療をカスタマイズし改善することで、神経障害者の回復率と生活の質を高めると予測されています。

神経リハビリテーション機器市場の需要を急増させる要因とは？

神経リハビリテーション機器市場は、予測期間中に技術開拓を推進すると予想されます。ロボット工学、仮想現実、ブレインコンピュータインターフェースの進歩が、これらの機器の能力を高め、神経学的回復により役立つものにしています。米国国立神経疾患・脳卒中ラボ（NINDS）は、神経科学研究に多額の投資を行い、2020会計年度には約22億7,000万米ドルを割り当て、新しい神経リハビリテーション技術の創出に取り組んでいることを示しています。この投資により、改善されたリハビリテーション技術の開発と導入が加速し、市場の成長が促進されるものと考えられます。

ヘルスケア支出の増加は、神経リハビリテーション機器市場の成長を押し上げる可能性が高いです。2020年の米国国民医療支出は9.7%増の4兆1,000億米ドルとなるなど、ヘルスケア支出の大幅な増加は、最新の医療技術への投資に対するコミットメントが高まっていることを示しています。このような世界の医療支出の動向は、これらの技術へのアクセスを増加させ、市場拡大を促進することによって、最先端の神経リハビリテーション機器の幅広い採用を支援しています。

患者のコンプライアンスは神経リハビリテーション機器市場の成長をどのように阻害するか？

患者のコンプライアンスは、これらの技術の効果や採用に影響を与えるため、神経リハビリテーション機器市場の成長に大きな影響を与えます。配合されたリハビリテーションレジメンを患者が高いレベルで遵守することで、より良い治療結果が得られ、神経リハビリテーション機器の需要が高まります。患者が治療に取り組み、治療計画に従えば、リハビリテーションプログラムの成功率は向上し、これらの機器の有用性が示され、さらなる投資と開発が促進されます。一方、コンプライアンスが低いと、機器の有効性が低下するため、市場の成長が鈍化する可能性があります。そのため、神経リハビリテーション機器市場の維持・開拓には、患者の参加とコンプライアンスの向上が不可欠です。

神経リハビリテーション機器の価格が高いことは、アクセスや購入のしやすさを制限することで市場の成長に影響を与えます。高価な技術は、資金力のあるヘルスケア施設や裕福な患者への使用を制限し、普及を制限して市場成長を鈍化させる可能性があります。技術開発はイノベーションを促進し、転帰を向上させるかもしれないが、経済的な障壁は依然として大きな問題です。製造上のブレークスルー、競合の増加、費用対効果の高いソリューションを通じてコストの課題に対処することは、これらの機器をより身近なものとし、市場成長を促進するために不可欠です。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主要調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 神経リハビリテーション機器市場：製品別

• 神経ロボットシステム
• ブレインコンピュータインターフェース
• ウェアラブルデバイス
• 脳刺激装置

第5章 神経リハビリテーション機器市場：用途別

• 脳卒中
• パーキンソン病
• 脳・脊髄損傷
• 脳性麻痺
• 多発性硬化症
• その他

第6章 神経リハビリテーション機器市場：エンドユーザー別

• リハビリテーションセンター
• 病院とクリニック
• 在宅ケア

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Bionik Labs
• Ectron Ltd.
• REHABTRONICS INC.
• DIH International Limited（Hocoma AG）
• Abbott Laboratories（St. Jude Medical Inc.）
• MagVenture A/S
• Helius Medical Technologies
• Ekso Bionics
• Rehab-Robotics Company Limited
• Neurodan
• Rex Bionics
• Ottobock SE & Co. KGaA
• NeuroMetrix, Inc.

第11章 市場展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 供給源と参考文献

Neurorehabilitation Devices Market Valuation - 2026-2032

In the neurorehabilitation devices market, the increased prevalence of neurological illnesses, such as stroke, Parkinson's disease, and spinal cord injuries, is a major driver. As the world population ages, the prevalence of these illnesses rises, resulting in a significant demand for effective rehabilitation options. Technological improvements have resulted in the development of novel neurorehabilitation devices that improve patient outcomes and increase independence. These factors all contribute to the growing need for neurorehabilitation devices. The market size surpass USD 2466.43 Million valued in 2024 to reach a valuation of around USD 6373.74 Million by 2032.

The growing emphasis on early intervention and patient-centered care is driving market expansion. Neurorehabilitation devices serve an important role in improving the quality of life for people with neurological impairments by allowing for speedier recovery and increased functional capacities. Supportive government measures and rising healthcare expenditures are creating a favorable environment for the market's growth. These combined factors are generating significant growth in the neurorehabilitation device market. The rising demand for cost-effective and efficient neurorehabilitation devices is enabling the market grow at a CAGR of 13.90% from 2026 to 2032.

Neurorehabilitation Devices Market: Definition/ Overview

Neurorehabilitation devices are specialized instruments that help people with neurological abnormalities regain or improve their motor, sensory, and cognitive abilities. These devices use a variety of technologies to aid in the rehabilitation process, including robotics, virtual reality, and brain-computer interfaces. They treat disorders such as stroke, traumatic brain injury, and neurodegenerative diseases using structured and customized therapy that aims to improve neuronal plasticity and functional recovery.

Neurorehabilitation devices are utilized in clinical settings to provide individualized rehabilitation regimens that improve patient results. For instance, robotic exoskeletons aid stroke sufferers in regaining motor function by guiding limb movements, whilst virtual reality systems provide interesting environments for cognitive and motor practice.

These devices show promise, with continual advances in artificial intelligence and machine learning improving their ability to adapt to unique patient demands. Real-time neurofeedback and more advanced brain-computer interfaces are projected to customize and improve therapy, thereby increasing recovery rates and quality of life for those with neurological disabilities.

What are the Factors that Surge the Demand for the Neurorehabilitation Devices Market?

The neurorehabilitation devices market are expected to propel the technological developments over the forecast period. Robotics, virtual reality, and brain-computer interface advances are boosting these devices' capabilities, making them more useful in neurological recovery. The National Institute of Neurological Disorders and Stroke (NINDS) has made a significant investment in neuroscience research, allocating nearly USD 2.27 Billion for fiscal year 2020, demonstrating its commitment to creating novel neurorehabilitation technology. This investment is likely to speed the development and implementation of improved rehabilitation techniques, hence boosting market growth.

The increase in healthcare expenditure is likely to boost the growth of the neurorehabilitation devices market. The significant increase in healthcare spending, as seen by a 9.7% increase to USD 4.1 Trillion in US national health spending in 2020, demonstrates an increasing commitment to investing in modern medical technology. This global growing trend in healthcare expenditure supports the broader adoption of cutting-edge neurorehabilitation devices by increasing access to these technologies and promoting market expansion.

How Does the Patient Compliance Hinder the Growth of the Neurorehabilitation Devices Market?

Patient compliance has a substantial impact on the growth of the neurorehabilitation device market because it influences the effectiveness and adoption of these technologies. High levels of patient compliance with prescribed rehabilitation regimens result in better outcomes, driving demand for neurorehabilitation devices. When patients are engaged and follow their therapy plans, rehabilitation program success rates improve, indicating the utility of these devices and driving further investment and development. Low compliance, on the other hand, can reduce a device's perceived effectiveness, thus slowing market growth. As a result, improving patient involvement and compliance is critical for maintaining and developing the neurorehabilitation devices market.

The high cost of neurorehabilitation devices has an impact on market growth by limiting access and affordability. Expensive technologies may limit their use to well-funded healthcare facilities or rich patients, restricting widespread adoption and slowing market growth. Although technological developments may promote innovation and enhance outcomes, the financial barrier continues to be a significant problem. Addressing cost challenges through manufacturing breakthroughs, increased competition, and cost-effective solutions is essential to making these devices more accessible and driving market growth.

Category-Wise Acumens

Will the Demand for Robotic Arms Propel the Neurorobotic Systems Segment?

Neurorobotic systems are now dominating the neurorehabilitation device market. Robotic arms are expected to create substantial expansion in the neurorobotic systems section of the neurorehabilitation device market. These modern robotic technologies improve the precision and effectiveness of rehabilitation by offering consistent and controlled support during therapy. Robotic arms improve patient outcomes by allowing for repetitive, task-specific exercises that promote neuronal plasticity, driving demand for neurorobotic systems. Their increasing integration into rehabilitation programs highlights their potential to transform neurorehabilitation, hence driving market growth in this category.

Exoskeletons are expected to fuel expansion in the neurorobotic systems section of the neurorehabilitation devices market. These exoskeletons provide total support and assistive mobility, improving the rehabilitation process by allowing patients with severe motor impairments to participate in meaningful physical activities. Their capacity to aid functional recovery through repetitive, regulated movements while also providing support during therapy makes them extremely effective in neurorehabilitation. The use of encompassing exoskeletons is expected to greatly boost the neurorobotic systems market, highlighting their expanding importance in advanced rehabilitation procedures.

The capacity to assess and quantify patient performance using these technologies has resulted in better treatment outcomes, making them the favored option for many rehabilitation centers.

Will the Trained Professionals Fuel the Hospitals & Clinics Segment for the Neurorehabilitation Devices Market?

The hospitals & clinics segment currently dominates the neurorehabilitation devices market. The presence of trained professionals will fuel expansion in the neurorehabilitation devices market's hospital and clinic segments. Skilled healthcare personnel are required to successfully adopt and optimize the use of modern neurorehabilitation technologies. Their knowledge ensures that patients receive proper, individualized therapy, allowing these devices to provide the most benefit possible. As hospitals and clinics continue to spend on training and hiring experienced personnel, they improve the quality and effectiveness of neurorehabilitation services, attracting more patients and increasing demand for these devices in the healthcare sector.

The neurorehabilitation devices market will propel the hospital and clinic segment combination of advanced facilities and trained experts. Advanced facilities equipped with cutting-edge neurorehabilitation devices, as well as qualified experts capable of utilizing this technology, ensure high-quality, tailored patient treatment. This collaboration improves the effectiveness of rehabilitation programs, bringing more patients to hospitals and clinics for treatment. As a result, demand for neurorehabilitation devices rises in these settings, driving market expansion in this sector.

Country/Region-wise Acumens

Will the Advanced Research and Development Boost the North American Region for the Neurorehabilitation Devices Market?

North America, holds a dominant position in the neurorehabilitation devices market. Advanced research and development are propelling the neurorehabilitation devices market in North America. The United States, in particular, is driving this effort with significant investments in neurological research and rehabilitation technologies. The National Institutes of Health (NIH) will spend around USD 9.7 Billion on brain research in fiscal year 2023, with a large chunk of that going toward neurorehabilitation. The National Institute of Neurological Disorders and Stroke (NINDS), got USD 2.8 Billion, up 3.5% from the previous year. The high frequency of neurological illnesses, such as 17% of children diagnosed with developmental impairments and 6.7 million Americans aged 65 and older living with Alzheimer's dementia, adds to this demand.

The well-established healthcare infrastructure will propel the neurorehabilitation devices market in North America. The United States and Canada, with their modern medical facilities and high adoption rates of cutting-edge technology, provide an ideal setting for market expansion. According to the American Hospital Association (AHA), there will be 6,093 hospitals in the United States in 2023, many of which will have cutting-edge rehabilitation departments.

The Centers for Medicare & Medicaid Services (CMS) estimated 1,166 inpatient rehabilitation centers in 2021, with specialized intensive care. The high prevalence of neurological illnesses, with the CDC estimating 795,000 strokes each year in the United States and the National Spinal Cord Injury Statistical Center reporting 17,900 new spinal cord injury cases each year, emphasizes the need for sophisticated neurorehabilitation technologies.

These factors emphasize a sizable patient population that could benefit from such devices, which is boosting demand for effective and novel neurorehabilitation solutions in North America.

Will the Urbanization and Increasing Disposable Incomes Expand the Asian Pacific Region for the Neurorehabilitation Devices Market?

The Asia-Pacific region is experiencing the most rapid growth in the neurorehabilitation devices market. Urbanization and increasing disposable incomes will fuel Asia Pacific's neurorehabilitation device market. Countries such as China, India, and Japan are undergoing fast urbanization and economic development, resulting in increased access to healthcare services and innovative medical technologies. According to UNESCAP, the region's urban population is expected to increase from 2.3 billion in 2019 to 3.5 billion by 2050, while the World Bank reports that GDP per capita in East Asia and the Pacific increased from $10,291 in 2010 to $14,480 in 2021, indicating a significant increase in purchasing power.

The prevalence of neurological disorders underscores this requirement, with the World Health Organization estimating that neurological disorders account for 6.8% of the overall disease burden in the Western Pacific and 8.7% in Southeast Asia. Furthermore, a 2023 study in The Lancet Neurology predicts that the number of persons with dementia in Asia Pacific will rise from 20.1 million in 2020 to 61.4 million by 2050. These considerations highlight the growing patient population in the Asia Pacific who could benefit from neurorehabilitation equipment, which is being driven by urbanization, increased incomes, and an increase in the prevalence of neurological illnesses.

Expanding healthcare awareness will drive the Asia Pacific neurorehabilitation devices market. In North America, rising public health education and patient empowerment in nations such as China, India, and Japan are leading to a greater understanding of neurological diseases and the benefits of rehabilitation therapies. As awareness rises, the region's large population of people suffering from neurological illnesses learns more about the importance of neurorehabilitation. This increased awareness, combined with a focus on improving long-term care and quality of life, is generating strong demand for neurorehabilitation equipment in the Asia Pacific region.

Competitive Landscape

The neurorehabilitation devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the neurorehabilitation devices market include:

• Bionik Labs
• Ectron Ltd.
• REHABTRONICS INC.
• DIH International Limited (Hocoma AG)
• Abbott Laboratories (St. Jude Medical Inc.)
• MagVenture A/S
• Helius Medical Technologies
• Ekso Bionics
• Rehab-Robotics Company Limited
• Neurodan
• Rex Bionics
• Ottobock SE & Co. KGaA
• NeuroMetrix, Inc.

Latest Developments

• In February 2023, MindMaze debuted Iza, a US Food and Drug Administration (FDA)-listed and CE-marked smart peripheral device for patients with weak hand motor abilities. Izar is intended to address a major vacuum in neurological care by providing the most effective treatment for manual dexterity and strength in a variety of neurological diseases.
• In September 2022, Sumitomo Pharma Co. Ltd. and MELTIN MMI agreed to launch and commercialize the MELTz(R) Hand Rehabilitation System. The product was co-developed by the aforementioned companies, but MELTIN acquired device certification as a distributor and manufacturer.
• In April 2022, Blackrock Neurotech purchased MindX to accelerate the development of highly superior brain-computer interface technologies. By merging its hardware DNA with MindX's software DNA, Blackrock hoped to increase neural data analysis while also providing flexibility and adaptation for a wide range of BCI applications.

Neurorehabilitation Devices Market, By Category

• Product:
• Neurorobotic Systems
• Brain Computer Interface
• Wearable Devices
• Brain Stimulators
• Application:
• Stroke
• Parkinson's Disease
• Brain & Spinal Cord Injury
• Cerebral Palsy
• Multiple Sclerosis
• End-User:
• Rehabilitation Centers
• Hospitals & Clinics
• Home Care
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Neurorehabilitation Devices Market, By Product

• Neurorobotic Systems
• Brain Computer Interface
• Wearable Devices
• Brain Stimulators

5. Neurorehabilitation Devices Market, By Application

• Stroke
• Parkinson's Disease
• Brain & Spinal Cord Injury
• Cerebral Palsy
• Multiple Sclerosis
• Other Applications

6. Neurorehabilitation Devices Market, By End-User

• Rehabilitation Centers
• Hospitals & Clinics
• Home Care

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Bionik Labs
• Ectron Ltd.
• REHABTRONICS INC.
• DIH International Limited (Hocoma AG)
• Abbott Laboratories (St. Jude Medical Inc.)
• MagVenture A/S
• Helius Medical Technologies
• Ekso Bionics
• Rehab-Robotics Company Limited
• Neurodan
• Rex Bionics
• Ottobock SE & Co. KGaA
• NeuroMetrix, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References